Pathway Genomics to Present at the 2017 UBS Global Healthcare Conference

Pathway Genomics, a commercial-stage genomics company, announced ahead of the weekend that Dr. Michael Nova, Chief Innovation Officer, and Kamal Adawi, Chief Financial Officer, will present at the 2017 UBS Global Healthcare Conference.

The event will be held at the Grand Hyatt in New York City on Monday, May 22nd through May 24th.

Pathway’s presentation will take place Monday, May 22, 2017 at 3:00 p.m. EDT.

We’re told that the presentation will be available on

“Pathway has a great relationship with UBS and we are honored to be a part of such an important conference,” said Jim Plante, Founder & CEO. “We are excited to share our upcoming advancements in genetic testing, artificial intelligence, personalized medicine and wellness.”

This post was written by:

- who has written 371 posts on mHealthWatch.

Contact the author